Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc. (ticker: RAPH) is an OTC-listed medicinal chemicals & botanical products company. DredgeCap's structured extraction of RAPH's SEC filings surfaces 7 active risk signals, including 5 late-filing signals, and 2 auditor-change signals. RAPH reported no tagged revenue in revenue and -$229K for the period ending 2026-03-31, with operating cash flow of -$44K. Cash and equivalents stood at $1K (down 98% year-over-year). Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.